Singapore markets closed

Ocuphire Pharma Inc (R3X1.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.5600+0.0020 (+0.13%)
As of 01:08PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-11,301
-9,986
17,888
-56,693
-24,620
-
Depreciation & amortisation
5
6
4
4
8
-
Stock-based compensation
3,691
3,510
1,807
1,914
1,506
-
Change in working capital
3,158
4,076
-5,555
181
1,146
-
Accounts receivable
910
372
-1,298
0
-
-
Accounts payable
-159
1,082
-515
381
792
-
Other working capital
-3,182
-1,112
14,314
-19,370
-6,797
-
Other non-cash items
-
1,328
-
1,614
16,660
1,409
Net cash provided by operating activities
-3,182
-1,112
14,314
-19,370
-6,797
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-
-25
Other investing activities
-
-
-
-100
539
-
Net cash used for investing activities
0
0
0
-100
539
-
Cash flows from financing activities
Debt repayment
-
0
-538
-108
0
-
Common stock issued
11,706
9,227
4,428
28,491
21,150
-
Other financing activities
-
-278
-131
-1,511
-1,779
-
Net cash used provided by (used for) financing activities
11,355
8,979
3,786
27,605
21,120
-
Net change in cash
8,173
7,867
18,100
8,135
14,862
-
Cash at beginning of period
38,988
42,634
24,534
16,399
1,537
-
Cash at end of period
47,161
50,501
42,634
24,534
16,399
-
Free cash flow
Operating cash flow
-3,182
-1,112
14,314
-19,370
-6,797
-
Capital expenditure
-
-
-
-
-
-25
Free cash flow
-3,182
-1,112
14,314
-19,370
-6,797
-